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BRIEF COMMUNICATIONS: RESEARCHBrief CommunicationsIn patients with severe heart failure, mechanical unloading
with the use of a left ventricular assist system (LVAS) has
been reported to lead to myocardial recovery, which
occasionally enables patients to undergo successful device
removal.1-3 However, there are no conclusive data on how
to predict a heart will sufficiently recover because the
LVAS imposes a specific situation.
The echocardiographic criteria previously proposed by
another group3 (left ventricular [LV] diastolic dimension<
55 mm, LV ejection fraction>45%) aid in the decision to
remove the LVAS. However, because of the severe limita-
tions of heart transplantation, we have adopted more liberal
criteria and accepted LV function below these values for
LVAS weaning unless the pulmonary capillary wedge pres-
sure increases during the device halt. We think these deci-
sion processes are still immature, and we are unable to
predict successful weaning.
The recent advance of multidetector computed tomo-
graphic angiography (MDCTA) provides various cardiac
parameters with high image quality and quantification possi-
bilities in a single image session.4 The present study showed
our initial experience with MDCTA as an alternative modal-
ity for accurate and informative functional analyses in
patients receiving the LVAS.
CLINICAL SUMMARY
The institutional review board approved the study, and
patients provided written informed consent. We performed
64-row MDCTA (GE Healthcare, Waukesha, Wis) to assess
cardiac function during the off-pump status in 3 patients who
underwent LVAS implantation for end-stage dilated cardio-
myopathy. At the time of examination, all patients regained
a normal range of end-organ function and sinus rhythm. Our
routine regimen1 to assess myocardial recovery had been
carried out before the MDCTA evaluation, and all patients
tolerated regular off-pump tests for at least 15minutes. Base-
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are shown in Table 1.
Before the image acquisition, the LVAS pump rate was
gradually decreased and the device was completely stopped
for 10 to 15 minutes after the administration of 3 mg/kg of
heparin. After injection of nonionic contrast of 0.8 mL/kg,
a volume data set of the whole heart (collimation 64
30.625 mm; gantry rotation time 350 ms; mean scanning
time<10 s) was acquired with retrospective electrocardio-
graphic gating. Functional measurements were evaluated
using commercially available software (AW Workstation,
GE Healthcare). Briefly, a stack of consecutive images
(10 phases, each of 5 mm thickness with a gap of 2 mm)
was reconstructed in the short-axis of each ventricle. Semi-
automated detection of epi- and endocardial borders with
manual correction was performed in end diastole and end
systole. The software automatically calculated biventricular
volumes and ejection fraction.
Image acquisitions were successful without any compli-
cations in the patients. The results of functional measure-
ments on MDCTA are shown in Table 2. MDCTA
clearly visualized the consecutive change of entire ventri-
cles without any blind area during the cardiac cycle
(Figure 1).
DISCUSSION
It has been reported that the data fromMDCTA can be used
to assessmultiple cardiac functional parameters in patientswith
heart failure.4 As we showed, MDCTA provides precise and
informative measurements that are comparable to those mea-
sured by conventional modalities, even in patients receiving
the LVAS during the temporal device-halt.
Because of the limited donor supply in Japan, we have
paid meticulous attention to the use of the LVAS as
a ‘‘bridge to recovery.’’1 However, reliable criteria to pre-
dict successful recovery have not been established. This
may reflect the limitations of ultrasound imaging, such as
its 2-dimensional nature and suboptimal windows for car-
diac measurements. Moreover, the use of the LVAS and
the strict anticoagulant therapy preclude assessments of
more detailed LV function and other cardiac parameters,
such as the right ventricular function by magnetic resonance
imaging or routine use of conventional ventriculography.
We recently reported detailed analyses about the importancergery c December 2008
Brief CommunicationsTABLE 1. Patients’ characteristics and results of regular off-pump test
Duration of LVAD
support
at examination (d)
Echocardiographic data Hemodynamic data
Patient
No. Age Sex Diagnosis Device
LVDd
(mm)
LVDs
(mm)
LVEF
(%)
Mean PAP
(mm Hg)
PCWP
(mm Hg) (L/min)
1 11 F IDCM Toyobo-LV 82 44 33 51 14 4 3.1
2 55 M IDCM Toyobo-LV 519 47 37 44 8 2 3.0
3 23 M IDCM Toyobo-LV 103 74 65 25 17 9 4.5
IDCM, Idiopathic dilated cardiomyopathy; Toyobo-LV, Toyobo-NCVC (National CardioVascular Center) with apical drainage; LVDd, left ventricular end-diastolic diameter;
LVDs, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; CO, cardiac
output.
TABLE 2. Cardiac measurements on multidetector computed tomographic angiography and outcomes
Patient
No.
Heart rate
(beats/min)
LVEDV
(mL)
LVESV
(mL)
LVEF
(%)
SV
(mL)
CO
(L/min)
RVEDV
(mL)
RVESV
(mL)
RVEF
(%) Outcome
1 79 82 45 45 37 2.8 134 104 22 Explantation
2 60 123 63 49 60 3.6 110 68 38 Explantation
3 71 301 243 19 58 4.1 175 143 19 Ongoing
LVEDV, Left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; SV, stroke volume; CO, cardiac output;
RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVEF, right ventricular ejection fraction.
FIGURE1. Three-dimensional reconstructive images of left (red wiremesh) and right (yellowwire mesh) ventricular endocardial surfaces in case 2. ED,End
diastole; ES, end systole.of echocardiographic measurements and hemodynamic
changes during the off-pump test (Goro Matsumiya, MD.
The 43rd Annual Meeting of the Society of Thoracic Sur-
geons, in 2007). Utility parameters derived from a noninva-
sive and accurate imaging tool are desirable to determine the
device removal.
Although future studies are still required, we think that
further experience using MDCTA will have an impact on
the assessment of myocardial recovery in patients with an
LVAS. This newer modality provides various cardiac mea-
surements easily and precisely without the use of invasive
approaches in a single image session.
LIMITATIONS
As found in other conventional modalities, there are in-
herent limitations of MDCTA, including the need for con-The Journal of Thoracic and Ctrast medium and radiation exposure. The effective
radiation dose of MDCTA was 11 to 18 mSv in our patients,
which was higher than that of conventional angiography.
These factors must be taken into account, and MDCTA
should not be used in all patients.
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